IP Library Patent Application 10888356
Patent Application
App. No. 10/888,356

Method and apparatus for fractional photo therapy of skin

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/888,356
Abstract

A method and apparatus for providing fractional treatment of tissue (e.g., skin) using lasers is disclosed. The method involves creating one or more microscopic treatment zones of necrotic tissue and thermally-altered tissue and intentionally leaving viable tissue to surround the microscopic treatment zones. The dermatological apparatus includes one or more light sources and a delivery system to generate the microscopic treatment zones in a predetermined pattern. The microscopic treatment zones may be confined to the epidermis, dermis or span the epidermal-dermal junction, and further the stratum corneum above the microscopic treatment zones may be spared.

Claims (61)

1 . A method for achieving beneficial effects in a target tissue in skin comprising treating the target tissue using optical radiation to create a plurality of microscopic treatment zones in a predetermined treatment pattern, wherein a subset of said plurality of discrete microscopic treatment zones includes individual discrete microscopic treatment zones comprising necrotic tissue volumes having an aspect ratio of at least about 1:2.

2 . The method of claim 1 , wherein the microscopic treatment zones are separated by thermally unaltered tissue.

3 . The method of claim 1 , wherein the microscopic treatment zones are surrounded by thermally altered heat shock zones comprising viable tissue.

4 . The method of claim 3 , wherein the heat shock zones are separated by thermally unaltered tissue.

5 . The method of claim 1 , wherein the microscopic treatment zones extend from the skin surface up to 4 mm into the tissue.

6 . The method of claim 1 , wherein the microscopic treatment zones extend from the skin surface to the epidermal-dermal junction.

7 . The method of claim 7 , wherein the microscopic treatment zones have a depth measured from the epidermal-dermal junction of the skin in a range up to about 4 mm into the dermis.

8 . The method of claim 1 , wherein the necrotic tissue volumes have a cross-sectional width in a range between about 10 μm and about 1,000 μm.

9 . The method of claim 8 , wherein the necrotic tissue volumes have a cross-sectional width in a range between about 25 μm and about 750 μm.

10 . The method of claim 9 , wherein the necrotic tissue volumes have a cross-sectional width in a range between about 50 μm and about 500 μm.

11 . The method of claim 2 , wherein the cross-sectional width of the viable heat shock zone is controlled by the predetermined treatment pattern.

12 . The method of claim 1 , where the predetermined treatment pattern of creating the microscopic treatment zones is accomplished by choosing one or more variables from the list comprising laser wavelength, chromophore, laser energy density, pulse energy, pulse duration, thermal diffusion constants and the temporal and spatial distribution of the laser energy.

13 . The method of claim 12 , wherein the chromophore is water.

14 . The method of claim 12 , wherein the pulse energy is less than about 150 mJ and the pulse duration is in a range between about 50 microseconds and about 100 milliseconds.

15 . The method of claim 12 , wherein the pulse energy is less than about 50 mJ and the pulse duration is in a range between about 400 microseconds and about 10 milliseconds.

16 . The method of claim 1 , wherein the ratio of the sum of the volumes of the microscopic treatment zones to the target tissue volume is less than one.

17 . The method of claim 1 , wherein the microscopic treatment zones have a physically intact stratum comeum.

18 . The method of claim 1 , wherein the necrotic tissue volumes are substantially columnar.

19 . The method of claim 1 , wherein the aspect ratio is greater than about 1:4.

20 . A method for achieving beneficial effects in skin tissue comprising treating the tissue by exposing a targeted part of the tissue to optical radiation to create a plurality of microscopic treatment zones such that the volume of the target tissue that remains substantially unaffected by the optical radiation is controlled.

21 . The method of claim 20 wherein the control is achieved by focusing the optical radiation to desired depths in the skin.

22 . The method of claim 20 wherein each microscopic treatment zone is thermally altered by the optical exposure.

23 . The method of claim 20 wherein each microscopic treatment zone is surrounded by a heat shock zone comprising viable tissue.

24 . The method of claim 20 wherein the microscopic treatment zone includes a necrotic tissue volume defined by a cross-sectional width in a range between about 10 μm and about 1,000 μm and a depth of up to about 4 mm in the direction of the optical radiation.

25 . The method of claim 20 comprising choosing a target region, using a hand piece to deliver laser energy to the target region, where the target region is treated by the movement of the hand piece over the target region when the area of the target region is greater than the cross sectional area of the hand piece.

26 . The method of claim 20 , wherein a subset of said plurality of discrete microscopic treatment zones includes individual discrete microscopic treatment zones comprising necrotic tissue volumes having an aspect ratio of at least about 1:2.

27 . A system for providing dermatological treatment comprising:

a source of optical radiation;

a means for delivering the optical radiation to a target volume of skin;

a control system that is operably connected to the source of optical radiation and the means for delivering the optical radiation;

the control system programmed to control the delivery of optical radiation to the target volume to create one or more microscopic treatment zones such that the volume of the target tissue that remains substantially unaffected by the optical radiation is controlled.

28 . A system for providing dermatological treatment, comprising:

a source of optical radiation;

a delivery system operably coupled to the source, the delivery system configured to direct said optical radiation to a volume of tissue in a predetermined pattern; and

wherein the predetermined pattern comprises a plurality of discrete microscopic treatment zones, wherein a subset of said plurality of discrete microscopic treatment zones includes individual discrete microscopic treatment zones comprising necrotic tissue volumes having an aspect ratio of at least about 1:2.

29 . The system of claim 28 , further comprising a source control system operably coupled to the source, the source control system configured to control a parameter of the optical radiation, wherein the parameter of the optical radiation includes at least one of wavelength, pulse duration, pulse energy, pulse shape, beam profile, chirp and repetition rate.

30 . The system of claim 28 , wherein the optical radiation has a beam cross-sectional width at the tissue surface of less than about 200 microns.

31 . The system of claim 28 , further comprising a delivery system controller operably coupled to the delivery system, the delivery system controller configured to control at least one of a plurality of delivery system parameters, the plurality of delivery system parameters including numerical aperture, focal length and optical radiation beam direction.

32 . The system of claim 31 , wherein the plurality of delivery system parameters further comprise scan speed, scan direction, de-blurring, number of optical radiation beams emitted simultaneously and pattern shape.

33 . The system of claim 28 , further comprising a contact window located between the delivery system and the tissue, and configured to contact the tissue when the system is in operation.

34 . The system of claim 33 , wherein the contact window comprises a material that is substantially transparent to the optical radiation and that has a high thermal conductivity.

35 . The system of claim 33 , wherein the source of optical radiation, the delivery system and the contact window are configured to cause a necrotic volume in an epidermal region within the tissue while substantially sparing a stratum comeum region adjacent to the epidermal region.

36 . The system of claim 28 , wherein the delivery system further comprises an optical system which includes at least one of a mirror, a lens, a lens array, a diffractive element, a holographic element and a fiber optic element.

37 . The system of claim 36 , wherein the optical system has a numerical aperture greater than about 0.005 and a focal point located in a range between about 500 microns above the tissue surface and about 1500 microns below the tissue surface.

38 . The system of claim 28 , wherein the delivery system further comprises a scanner system which includes at least one of a one-dimensional scanner and a two-dimensional scanner.

39 . The system of claim 38 , wherein the scanner system includes at least one of an acousto-optic element, a piezoelectric element, a galvanometer, a micro-electro-mechanical system (MEMS), a rotating mirror, a rotating prism, an optical mouse and a mechanical mouse.

40 . The system of claim 28 , wherein the necrotic tissue volumes have a diameter at the tissue surface of less than about 200 microns.

41 . The system of claim 28 , wherein the necrotic tissue volumes have a depth of at least about 200 microns.

42 . The system of claim 28 , wherein the discrete microscopic treatment zones have a physically intact stratum comeum.

43 . The system of claim 28 , wherein the discrete microscopic treatment zones are substantially columnar.

44 . The system of claim 28 , wherein the centers of the necrotic zones for the discrete microscopic treatment zones are separated by at least 50 microns.

45 . The system of claim 28 , wherein the predetermined pattern includes uniformly spacing the discrete microscopic treatment zones.

46 . The system of claim 28 , wherein the predetermined pattern includes a total number of discrete microscopic treatment zones in a range up to about 2500 per square centimeter.

47 . The system of claim 28 , wherein the optical radiation has a wavelength in a range between about 400 nm and about 12,000 nm, an energy up to about 150 mJ per pulse and a pulse duration up to about 100 milliseconds.

48 . The system of claim 28 , wherein the optical radiation has a wavelength in a range between about 900 nm and about 3,000 nm, an energy up to about 50 mJ per pulse and a pulse duration in a range between about 400 microseconds and about 10 milliseconds.

49 . The system of claim 28 , wherein the individual discrete microscopic treatment zones include heat shock zones, the heat shock zones and the necrotic tissue volume for the individual discrete microscopic treatment zones form a substantially cylindrical combined volume, the substantially cylindrical combined volume has an aspect ratio of at least about 1:1.

50 . The system of claim 28 , wherein the ratio of the sum of the surface areas of necrotic tissue and heat shock zone to the sum of the surface area of untreated tissue within the target tissue volume is less than one.

51 . The system of claim 28 , wherein the source of optical radiation comprises one or more of a fiber laser, a diode laser, a carbon-dioxide laser, a diode-pumped solid state laser, a ruby laser, and optical parametric oscillator or an excimer laser.

52 . The system of claim 28 , wherein the system causes an optical fluence incident on the surface of the tissue in a range between about 0.001 Joules per square centimeter and about 100,000 Joules per square centimeter.

53 . The system of claim 28 , wherein the aspect ratio is greater than about 1:4.

54 . The system of claim 28 , wherein the delivery system further comprises a handpiece, the system configured to produce up to 2500 necrotic tissue volumes per square centimeter while the handpiece is moving at a speed in a range between about 1 centimeter per second and about 6 centimeters per second.

Assignments (9)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: SILICON VALLEY BANK
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 032125/0810 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 032126/0708 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: RELIANT TECHNOLOGIES, LLC
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0527 →
SECURITY INTEREST - MEZZANINE LOAN Recorded Apr 18, 2013
From: RELIANT TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 030248/0256 →
SECURITY AGREEMENT Recorded Jun 16, 2009
From: RELIANT TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 022824/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2007
From: BLACK, MICHAEL
To: RELIANT TECHNOLOGIES, INC.
Reel/Frame 020178/0509 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2005
From: BLACK, MICHAEL
To: RELIANT TECHNOLOGIES, INC.
Reel/Frame 016986/0067 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2005
From: BLACK, MICHAEL
To: RELIANT TECHNOLOGIES, INC.
Reel/Frame 016986/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2004
From: DEBENEDICTIS, LEONARD C.; HERRON, G. SCOTT; SINK, ROBERT KEHL; EIMERL, DAVID; LEMBERG, VLADIMIR; VOEVODKIN, GEORGE
To: RELIANT TECHNOLOGIES, INC.
Reel/Frame 015352/0970 →